Editorial Staff

Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Related research: Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Get new episodes of Hubwonk in your inbox!

Related Posts:

Tilting Offshore Windmills: Speaking Truth to Ratepayers

Joe Selvaggi talks with energy economist Dr. Jonathan Lesser about the chasm between the promises and realities of offshore wind projects, including the likely increased costs passed to electricity consumers and taxpayers.

Picking Patients’ Pockets: Exposing Insurance Schemes Targeting Orphan Diseases

Joe Selvaggi talks with Pioneer Institute’s senior Health Care Fellows Dr. Bill Smith and Dr. Robert Popovian about their white paper "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Out-of-Pocket Assistance Programs." This episode explores what consumers and regulators can do to ensure those with rare diseases are not left without assistance.

Erec Smith on the Rhetoric of Anti-racist Activism

Joe Selvaggi talks with York College of Pennsylvania Associate Professor Eric Smith about the disempowering effects of modern anti-racism movement and the challenges for thought leaders who espouse more constructive narratives.

Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.

Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”

Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Bank of Big Brother: Exploring a National Digital Currency Future

Joe Selvaggi talks with financial privacy and digital currency expert Nicholas Anthony of CATO Institute Center for Monetary and Financial Alternatives about the potential benefits and risks were the U.S. to adopt a national digital currency.

Transparency, Please! MBTA Resists Disclosure of Arbitration Award

Joe Selvaggi talks with attorney for Pioneer Public Interest Law Center (PPILC) John La Liberte, about the work he did to successfully gain access to the MBTA retirement fund’s arbitration agreement after a seven-month legal struggle.

Losing Talent and Treasure: Uncompetitive Tax Regime Drives Upper-Income Exodus

Joe Selvaggi talks with Pioneer Institute's Economic Research Associate Aidan Enright about his new paper "Debunking Migration Myths." With this research, Aidan examines the link between Massachusetts' tax regime and the outflow of high earners to states with more competitive rates.

Rationing Vital Therapies: Should Healthcare Experts Decide Who Lives?

Joe Selvaggi talks with senior health care fellow Dr. William Smith about his new book Rationing Medicine: Threats From European Cost Effectiveness Models to Seniors and Other Vulnerable Populations, and the book’s cautionary warning against embracing European standards for valuing life saving therapies.

Transparent Home Buying: Real Estate Auction Platform Informs and Empowers Everyone

Joe Selvaggi talks with Tim Quirk and Kevin Caulfield, cofounders of Boston based technology startup, Final Offer, about the way in which their recently launched platform disrupts the traditional home buying process by providing a real time transparent auction for each sale.